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ABSTRACT
Lactobacillus species are widely accepted as beneficial bacteria of the
human microbiota1-8. Lactobacilli spp. are well documented to inhibit pathogens
by production and secretion of hydrogen peroxide (H2O2), organic acids, and/or
proteinaceous bacteriocins into their environment. Most research attributes
bactericidal activity of cell free supernatant (CFS) to H2O2 and/or lactic acid.
Here, I demonstrate that CFS from a clinical isolate of Lactobacillus crispatus
contains a molecule(s) that inhibits uropathogenic Escherichia coli (UPEC)
colony formation independently of H2O2 and organic acids. Physiologic
concentrations of H2O2 and organic acids produced by L. crispatus do not inhibit
UPEC colony formation. Incubation of UPEC with L. crispatus CFS has a
bactericidal effect on UPEC that begins at about 4 hours and results in
undetectable CFUs by 16 hours, apparently the result of severe plasmolysis.
Bactericidal activity of this CFS is effective against some Gram-negative and
Gram-positive species including multidrug resistant (MDR) E. coli. The broadspectrum activity shows CFS may have applicability as future therapeutic for
treatment of various bacterial infections including MDR infections.
The active molecule(s) present in CFS is stable over a wide temperature
range and can be stored for at least 3 months while retaining full bactericidal
activity. The active molecule(s) is sensitive to dilution and increased salt
xvi

concentrations. The active molecule(s) from CFS can be isolated via organic
extraction. Based on the extraction profile, the molecule is predicted to be a
dipolar organic molecule(s). The majority of proteins and tri-peptides are
removed during organic extraction yet extracts retain full bactericidal activity. I
conclude that L. crispatus produces a very stable potentially novel dipolar,
organic molecule with broad-spectrum activity that is concentration-dependent
and salt-sensitive, and which results in plasmolytic activity against its target.
Isolation and identification of this molecule(s) could lead to application as a
decontaminant or therapeutic.
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CHAPTER I
INTRODUCTION
Previous Wolfe Laboratory Research
Lactobacillus species are widely accepted as beneficial bacteria present in
the gastrointestinal or vaginal tracts1-4, and recently within the lower urinary
tract5-8. Using a novel culture technique, the Enhanced Quantitative Urine Culture
(EQUC), members of the Wolfe laboratory have cultured organisms from the
bladders of women with and without urinary bladder symptoms5-8. Lactobacillus
crispatus was the most commonly cultured species from healthy controls without
lower urinary tract symptoms9. Intriguingly, Lactobacillus crispatus and
Escherichia coli rarely co-occurred9. This finding led Travis Price, a former MS
student in the Wolfe laboratory, to investigate interactions between commonly
cultured Lactobacillus species and Escherichia coli, which is implicated in
numerous disorders of the urinary and reproductive tracts.
Travis Price and Katherine Diebel, another former MS student in the Wolfe
laboratory, have documented inhibition of uropathogenic Escherichia coli (UPEC)
by a clinical isolate of Lactobacillus crispatus, Lc409-10. By first analyzing EQUC
co-culture frequencies, Price noticed a low co-culture rate between L. crispatus
and E. coli from samples obtained from the urinary bladder. Thus, he tested
possible interactions between these species by performing a Spotted Lawn
1
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assay. Price reported that Lc40 cells, but not cell free supernatant (CFS),
inhibited the growth of uropathogenic and clinically obtained E. coli strains9 on
agar plates. No zone of inhibition developed around the Lc40 cell spots,
suggesting that inhibition by L. crispatus is contact-dependent. However, Price
also determined that Lc40 CFS could inhibit the growth of UPEC in liquid culture
and had considerably more activity against UPEC than did other species of
Lactobacillus9. This finding would suggest L. crispatus has multiple mechanisms
for the inhibition of other bacteria or the molecule(s) responsible for inhibition is
not diffusible across/through agar plates. Because lactic acid and H2O2 are
diffusible, this observation would suggest that these molecules are not
responsible for Lc40’s ability to inhibit UPEC growth on agar plates. His results
using L. gasseri differed from L. crispatus. L. gasseri cell spots on E. coli lawns
did not show a zone of inhibition surrounding the spotted cells. Similar to L.
crispatus, L. gasseri CFS was ineffective under plated conditions In contrast to L.
crispatus, L. gasseri CFS partially inhibited UPEC in liquid cultures, but its did not
effect was substantially less complete.
Katherine Diebel repeated the work of previous researchers, by heating
CFS or treating CFS with catalase10. In contrast to the former reports2,11, there
was no increase of viable E. coli CFUs incubated in treated CFS when compared
to untreated CFS10, suggesting that treatment of CFS does not decrease its
efficacy. Diebel also validated that the bactericidal activity of CFS was pH
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dependent against UPEC
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by showing CFS buffered above pH 4.78 lost its

inhibitory effect10.
Together, the research of Price and Diebel has warranted further
investigation into the inhibitory molecules of CFS as well as the mechanism of
action against target cells. If a secreted molecule(s) is responsible for inhibition
then it may have potential application as a future therapeutic.
Common Lactobacilli Isolated from the Urinary Bladder
The most commonly cultured Lactobacillus species from urinary bladder
samples of women were L. crispatus, L. gasseri, L. iners, and L. jensenii13. This
finding is consistent with research studying the vaginal microbiome14, where the
four most commonly occurring Lactobacilli are the same as the four species of
the urinary bladder. Three of these Lactobacillus spp. are associated with a
healthy flora of the vaginal microbiota14-17. Research on the vaginal microbiota
shows that an absence or decrease in Lactobacilli is associated with various
disease states14-17. Research into the urinary microbiota is consistent with
findings of the vaginal niche14,18.
L. crispatus is commonly used as a probiotic and is widely accepted as a
beneficial bacterium15-17,19-20. L. crispatus has been shown to have antimicrobial
activity against many pathogenic bacterial species, including E. coli, Gardnerella
vaginalis, and Chlamydia trachomatis1,19,21. It also may have the ability to
regulate the vaginal microbiota by maintaining a Lactobacillus dominant flora
rather than converting to a non-Lactobacillus dominant flora22. L. crispatus
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maintains a Lactobacillus dominant microbiota better than L. gasseri or L. iners
predominant women. Beyond the urogenital environment, L. crispatus is often
used in the production and processing of dairy and fermented food products23.
Use in the food industry is due to its anti-spoilage and anti-pathogenic properties.
There have not been any documented detrimental aspects of L. crispatus
colonization in various anatomical niches including both the urogenital and
gastrointestinal tracts.
L. gasseri is another commonly used organism in probiotics15-17,19-20.
When used as a probiotic, it is speculated to assist in weight reduction in
individuals who are overweight or obese24. L. gasseri has also been proposed to
prevent periodontal disease and assist in immune system regulation when
present in the gastrointestinal tract25. It has shown to be effective against
pathogens such as E. faecalis, H. pylori, and L. monocytogenes23,26. It does not
appear to have any negative effects on human health.
L. jensenii has been genetically modified to express human cell surface
proteins (e.g. CD4) or to secrete antiviral drugs27-28 (e.g. cyanovirin-N). Both
altered isolates were shown to reduce HIV infectivity. L. jensenii also inhibits
Neisseria gonorrhoeae29. Similar to L. crispatus, L. jensenii is used during milk
processing and fermentation processes due to antioxidant properties30. In
contrast to both L. crispatus and L. gasseri, L. jensenii has been reported to
cause disseminated infective endocarditis31. However, L. jensenii-induced
endocarditis is rare.
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Although it is one of the most commonly cultured Lactobacilli, L. iners
has not been shown to have any inhibitory or protective potential16,22,32. Women
predominanted by L. iners are more susceptible to bacterial vaginosis than
woman colonized by other Lactobacillus spp16. Analysis of the L. iners proteome,
may suggest that specific proteins produced are possibly associated with vaginal
dybiosis32.
In general, the female urogenital tract is predominantly colonized by only
one species of Lactobacillus. Both L. crispatus and L. gasseri have the most
documented benefits to human health without documentation of detriment. Based
on research performed by Travis Price, clinical isolates of L. crispatus have
greater inhibitory activity against pathogens than L. gasseri. L. crispatus is also
the most widely recognized beneficial Lactobacillus species among published
research.
Hydrogen Peroxide and Organic Acids
Lactobacillus spp. are well documented to produce hydrogen peroxide
(H2O2) and organic acids. Some species are also recognized to produce
antimicrobial bacteriocins. H2O2 acts by inducing oxidative stress on target cells
leading to the damage of cellular components including proteins, lipids, and
nucleic acids33. Oxidative damage to nucleic acids results in irreversible
alterations to the bacterial genome that ultimately results in death. Organic acids
can act by permanently damaging target cell membranes or by permeabilizing
the membrane, allowing antimicrobial molecules to enter target cells34.
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Bacteriocins are sorted into multiple groups, which act against their target using
different mechanisms.
Both H2O2 and organic acids are secreted by Lactobacilli into their
surrounding environment. Studies focusing on products secreted by Lactobacilli
have used CFS derived from spent culture media to evaluate the antimicrobial
effects of these secreted molecules. While many studies state that some
Lactobacilli produce bacteriocins35-40, most of those studies attribute the
bactericidal effects to lactic acid and/or H2O22,11,41-42. However, treatment of CFS
with catalase or high temperatures to degrade H2O2 results in only moderate
decreases in CFS efficacy against uropathogenic E. coli (UPEC), and not
complete inhibition11,41-42. Additionally, it has been demonstrated that de Man,
Rogosa, and Sharpe (MRS) broth, the standard culture medium for Lactobacilli,
facilitates the rapid decomposition of H2O243. Rodrigeuz et al. supplemented
MRS broth with 1-100mM H2O2 and measured OD405 over time. H2O2
concentrations were determined to decrease over time by 90% of the originally
supplemented concentration within a 24-hour period. In contrast, distilled water
or phosphate-buffered saline supplemented H2O2 retained initially added H2O2
concentrations when measured 24 hours after addition of H2O2. Based on these
findings, it would seem unlikely that H2O2 is responsible for the bactericidal
effects observed in untreated CFS.
The previously cited studies2,11 did not determine the physiologic levels of
lactic acid or H2O2 produced by the Lactobacillus species. These studies also did
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not test physiologic concentrations of H2O2 or lactic acid, either individually or
combined, against pathogens of interest. Instead, they tested arbitrary ranges of
concentrations for each molecule to determine the minimum inhibitory
concentration. The concentration of lactic acid produced by Lactobacillus spp.
has been measured as ~62mM11. This concentration has been shown to only
minimally inhibit pathogen colony formation11. Acetic acid concentrations have
been measured in liquid cultures of L. sanfrancisco CB1 CFS as 13.8mM44, but
the concentration produced by other Lactobacillus spp. has not been cited. H2O2
production by various Lactobacilli has been measured with values ranging from
0.03 to 2.6mM45. Inhibitory concentrations of H2O2 necessary to achieve
inhibition required 2.5mM or greater, depending on the target pathogen11.
Additionally, the physiologically produced concentrations of H2O2 would degrade
in MRS broth, according to findings of Rodriguez et al43.
When utilizing Dulbecco’s Modified Eagle Medium (DMEM) to neutralize
the effects of lactic acid, CFS bactericidal activity was decreased, but still
maintained some activity against some pathogens2,11. Unfortunately, the pH of
the media supplemented with DMEM was not documented. Antimicrobial activity
of some Lactobacilli CFS has been shown to be pH dependent and therefore pH
cannot be negated as a factor in pathogen viability10,12. These investigators
attributed inhibition solely to lactic acid and/or H2O2 and not the presence of other
organic acids that may have been produced by Lactobacilli species. Research
has shown that lactic acid and H2O2 can inhibit UPEC11,41-42; but, to achieve
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these results, greater concentrations than are physiologically relevant must be
used. This suggests that a molecule(s) other than lactic acid or H2O2 may be
responsible for the remainder of UPEC inhibition.
Antimicrobial Peptides and Bacteriocins
Many pathogens have developed antibiotic resistance with associated
increases in morbidity and mortality46. The increased rate of antibiotic resistance
exceeds the development and identification of new antibiotic that may be
effective against resistant strains. Consequently, only a limited cache of
antibiotics exists to combat bacterial infections. Various bacterial species have
been identified to produce molecules with bactericidal activity that may have
application as new antibiotic treatments. For instance, recently researchers have
identified lugdunin, a bacteriocidal molecule produced by Staphylococcus
lugdunensis with efficacy against the colonization of methicillin-resistant
Staphylococcus aureus, Glycopeptide intermediate-resistant S. aureus,
vancomycin-resistant Enterococcus, and other infectious bacteria47. L. crispatus
CFS also may contain many excreted, secreted or sloughed factors, which would
include possible antimicrobial peptides and/or bacteriocins. If Lactobacillus
crispatus CFS contains a molecule that is effective at inhibiting a broad spectrum
of pathogens, then the molecule may be effective against antibiotic resistant
strains with downstream application as an antimicrobial agent.
Antimicrobial peptides (AMPs) are small molecular weight peptides with
broad spectrum activity48-51. Various AMPs have been identified and determined
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to be produced by most organisms ranging from bacteria to mammals. AMPs
tend to be amphipathic molecules and this characteristic allows for selective
targeting of lipopolysaccharide membranes resulting in pore formation and loss
of cellular membrane integrity. Researchers have also found correlations
between AMPs and the mammalian immune response50-51.
Four major classes of AMPs have been identified. AMPs are classified
based on their target organism48. The bactericidal activity of all AMPs involves
the compromised integrity of cellular envelopes or membranes. Antiviral peptides
act against viruses by integrating into the viral envelope52-53. Antibacterial
peptides target bacterial membranes and act by compromising the bacterial lipid
bilayer membrane54-55. Antifungal peptides can act by targeting either fungal
membranes or internal cellular components56-57. Antiparasitic peptides form
pores in the membranes of parasites58-59.
Some bacterial species produce bacteriocins, which are proteinaceous
molecules that have antimicrobial activity against closely related species35-36,39.
Many bacteriocins have also been determined to be effectively bactericidal in
nano- and picomolar concentrations. Beyond antimicrobial activity, some
bacteriocins have been evaluated for their potential application as therapeutics
including anticancer agents60. Bacteriocins are synthesized by ribosomes and
are often encoded by plasmids, instead of the core genome of the producing
bacterium38. Bacteriocins are classified based on numerous criteria, including but
not limited to: method of production, mechanism of action, molecular weight, and

37
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chemical properties . Classification of bacteriocins differs between Gramnegative and Gram-positive bacteria. Bacteriocins produced by Gram-negative
species are generally classified based solely on size. Bacteriocins produced by
Gram-positive species are classified based on the previously stated criteria and
are grouped into Classes I-IV with some classes further separated into
subclasses35,37-38. As L. crispatus is a Gram-positive bacterium, I will focus solely
on Gram-positive bacteriocin classifications.
Class I bacteriocins are comprised of the lantibiotics that include the
amino acid lanthionine and its derivatives. They are small (<5 KDa) in size and
insensitive to protease degradation40. They are synthesized by Gram-positive
bacteria and post-translationally modified to form intramolecular ring structures40.
Intramolecular rings are formed through thioether bonds of internal cystine
residues of lanthionine amino acids40. Two types of lantibiotics exist40. Type A
lantibiotics are elongated, flexible, amphipathic peptides that act by forming
pores in the cytoplasmic membrane of Gram-positive bacteria. By contrast, Type
B lantiobiotics have a rigid, globular form and inhibit peptidoglycan synthesis of
Gram-positive bacertia.
The Class II bacteriocins are heat-stable, allowing them to retain structure
and function at elevated temperatures ranging from 100°C-121°C37-39. They do
not contain lanthionine amino acids or its derivatives, have molecular weights
<10 KDa, and tend to be amphipathic molecules with net positives charges.
Class II bacteriocins are sub-categorized into subclasses based on genetic
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consensus sequences. Class IIa are considered to be listeria-active
bacteriocins but have overall broad range activity. However, the broad range of
activity is not well defined. If this subclass acts on organisms that are
phylogenetically distant from the producing organism than these molecules do
not fit the definition of a bacteriocin. These act against their target by
permeabilizing cellular membranes61. Class IIb bacteriocins require two peptides
for activity and compromise bacterial membranes by pore formation62. Subclass
IIc bacteriocins are cyclic, thiol activated peptides that require cysteine residues
for activity63. Two additional, but minor, subclasses are subclass IId and IIe.
Class III bacteriocins are larger in size (>30 KDa) than Class I or II64. This
class contains proteins with enzymatic function. Subclass IIIa degrade cellular
membranes leading to cell lysis. Subclass IIIb act by altering cell membrane
potential leading to ATP efflux from cells, and ultimately cell death. Class III
bacteriocins are heat-labile and denature with increased temperature.
Class IV bacteriocins do not have definitive classification criteria.
Molecules placed into Class IV do not meet the criteria of the previously
mentioned classes. These are considered complex bacteriocins and are
generally conjugated with carbohydrates or lipids38,65-66. Other characteristics of
molecules in this class vary and there is not a currently identified consensus
sequence allowing for grouping into Class IV.
Lactobacillus CFS has been tested on a wide range of bacteria with
varying phylogenetic relatedness2-4,11-12,34,44-45,47,67-69. However, Escherichia and
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Salmonella, both phylogenetically unrelated to Lactobacillus, are susceptible to
Lactobacillus CFS11-12,67. Because bacteriocins are defined as only being
bactericidally active against closely related organisms, the activity of
Lactobacillus CFS does not fit into the classical definition of a bacteriocin. This
suggests that the active molecule against these genera is not likely to be a
bacteriocin.
Proteins and polysaccharides tend to be very immunogenic and therefore
one would expect increased cytokine production if the inhibitory molecule were
one of these two compounds. Nucleic acids and lipids tend to not induce an
immune response. Researchers have incubated vaginal epithelial cells with CFS
from L. crispatus reference strain CTV05 and documented that they do not
exhibit an immune response, as measured by pro-inflammatory cytokine levels1.
Therefore, based on previous observations, it would be suggested that the
inhibitory molecule present in Lc40 CFS is unlikely to be a protein or
polysaccharide.
Lc40 CFS activity has been shown to be insensitive to heat and has broad
spectrum activity against phylogenetically unrelated genera. Due to these results
it would seem unlikely that the bactericidally active molecule(s) in Lc40 CFS is a
bacteriocin, with the exception that it may be a Class IIa bacteriocin. I
hypothesize that the bactericidal molecule(s) of Lc40 CFS is likely an
antibacterial AMP.
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Inhibition and Mechanism of Action
A mechanism of action for the inhibition of bacteria by Lactobacillus CFS
has not been proposed. Spotted lawn assays were performed using Lc40 cells or
filter sterilized CFS. Under plated conditions Lc40 cells, but not CFS, had an
inhibitory effect against UPEC. Yet, liquid cultures containing CFS do have
inhibitory effects. This may suggest Lc40 has more than one mechanism of
inhibition or the molecule produced is either hydrophobic or has a low solubility.
Based upon data presented by others it seems unlikely bacterial inhibition
by L. crispatus is due to classically defined bacteriocins, lactic acid, or H2O2. The
necessity to use greater than physiologically produced concentrations of lactic
acid and H2O2 to achieve inhibitory effects shows that inhibition cannot be
attributed to either of these molecules1-3,11,44-45,68,70. Due to the heat stability of
CFS and phylogenetic distance between L. crispatus and E. coli, the inhibitory
effect is also not likely to be due to a bacteriocin, peptide, or protein. If the active
molecule(s) is a bacteriocin then it is either a Class II bacteriocin or a previously
unidentified class. It is being suggested that L. crispatus produces a potentially
novel molecule, or class of bacteriocin not previously identified, which I intend to
identify.
If L. crispatus produces a novel molecule that could be used as a
decontaminant or therapeutic, then we must understand the mechanism of
action. Knowledge of the mechanism would help evaluate the spectrum of activity
against pathogenic and non-pathogenic bacterial strains. If this molecule acts
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against pathogens with little or no damage to commensal bacteria of the host,
then this could be a good therapeutic. However, similar to many antibiotic
treatments, if this molecule eliminates commensal/symbiotic bacteria of the host,
then it may have negative downstream effects on host health. As a mechanism of
action for the inhibition of pathogens has not been investigated, the morphology
and integrity of target cells has not been characterized. This should be a first step
in order to understand the mechanism by which inhibition of colony formation
occurs.
Through my research, I intend to identify the bactericidal molecule(s)
present in CFS and determine a mechanism of action.

CHAPTER II
MATERIALS & METHODS
Bacterial Strains and Culture Conditions
Culture Conditions
Escherichia coli E. coli (CFT073, NU14, or UMB901) was plated on
Blood Agar plates (BAP) from a frozen stock. Plates were then incubated at 37°C
aerobically for 24 hours. After 24 hours, a single colony was obtained from BAP
and used to inoculate 6 mL of Tryptic Soy Broth (TSB). The culture was then
incubated at 37°C aerobically on a shaker for 24 hours.
Enterococcus faecalis E. faecalis clinical isolate UMB891 was plated on
BAP from a frozen stock. Plates were incubated in 5% CO2 at 37°C for 48 hours.
After 48 hours, multiple colonies were transferred using a sterile cotton swab
from BAP into 6 mL TSB supplemented with 5% FetalPlex™ animal serum
complex (Gemini Bio-Products). The inoculum was incubated at 37°C in 5% CO2
for 48 hours.
Lactobacillus crispatus Clinical isolate Lc40 of L. crispatus was plated
onto BAP from a frozen stock and incubated in 5% CO2 at 37°C for 48 hours.
After 48 hours, multiple colonies were transferred from BAP into 6 mL de Man,
Rogosa, and Sharpe (MRS) Broth71. The culture was then incubated statically in
5% CO2 at 37°C for 48 hours.
15
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Staphylococcus aureus S. aureus clinical isolate UMB910 was plated
in BAP from a frozen stock and incubated aerobically at 37°C for 24 hours. After
24 hours, a single colony was obtained to inoculate 6mL TSB. The inoculum was
then incubated aerobically at 37°C statically.
Sample Preparation
E. coli, E. faecalis, and S. aureus 100 µL of overnight cultures (O/N)
were added to 900 µL of TSB. The optical density (OD600) of these cultures was
then obtained using the Eppendorf BioPhotometer® D30 with TSB as a blank. All
samples were then standardized to a final an OD600 of 1.0.
L. crispatus 48-hour liquid cultures were centrifuged at 3500 rpm for 10
minutes to pellet bacterial cells. The supernatant liquid was then filter sterilized
using a 0.22µm filter to remove bacterial cells and obtain a cell free supernatant
(CFS). To determine CFS activity over Lc40 growth OD600 was measured every
six hours. 48-hour liquid cultures were standardized to an OD600 of 0.05 in 6 mL
of MRS. Measurements were obtained using MRS medium as a blank. Samples
were measured by adding 100 µL of culture to 900 µL of MRS to measure a 1:10
OD600.
Inhibitory Molecule Concentrations
Hydrogen Peroxide Concentration
Hydrogen peroxide concentrations were determined by titration72. CFS
was prepared as indicated in Methods Sample Preparation. Hydrogen Peroxide
(H2O2) concentration in CFS was determined by titration of potassium

72
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permanganate (KMNO4) into CFS diluted in water and sulfuric acid (H2SO4) .
KMNO4 is a purple solution, whereas the CFS solution is clear. As KMNO4 is
titrated into the CFS solution, it will gradually turn from a clear to pink solution,
but will revert rapidly back to clear. Once an equivalence point is reached, the
solution will remain pink. The volume of KMNO4 needed to reach equivalence is
then used to determine the concentration of H2O2 in CFS. Sterile water and a
commercial 3% H2O2 solution were used as negative and positive controls,
respectively.
Organic Acid Concentration
Acetic and lactic acid concentrations in CFS were determined using
commercially available kits from Boehringer Mannheim73,74.
Protein Quantification
The bicinchoninic acid assay (BCA) was followed per supplier
instructions75 to quantify protein concentrations in MRS and CFS. The samples
were read at 562 nm using Molecular Devices SpectraMAX 250 plate reader and
SOFTmax Pro software. Bovine Serum Albumin was used as the standard.
Quantification of Conditioned Medium Effect against E. coli
UPEC Incubation with CFS, Conditioned-Medium, and MRS
The volume of overnight UPEC cultures grown in TSB needed for an
OD600 of 1.0 in a final volume of 200 µL was determined. The determined
volume was added to 100 µL CFS, conditioned medium, or MRS. Cultures were
then brought to a final volume of 200 µL by addition of TSB. The mixed samples
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result in a final UPEC OD600 of 1.0 (~1.0x10 cells). Samples were prepared
in 96 well plates. Wells were covered with Parafilm™ to prevent evaporation of
samples. Plates were then incubated at 37°C aerobically on a shaker overnight.
Serial Dilutions
Serial dilutions were performed in 96 well plates with each well containing
180 µL Phosphate Buffered Saline (PBS) or dH2O. 20 µL of sample were added
to the first row using a multi-channel pipette. Samples were then mixed by
pipetting samples ~30 times before transferring 20 µL to the next row. Pipette
tips were changed between sample transfers. This row was mixed using the
above method and 20 µL transferred to the next well. 1:10 serial dilutions were
carried out by repeating this process through the 8th row of the 96 well plate
(Figure 1).
20 μL of original
sample

Transfer 20 μL of
previous dilution to
subsequent well

Figure 1. Serial dilutions performed in a 96-well plate
Cell Quantification
Samples from each well were plated onto Tryptic Soy Agar (TSA) plates.
Plates were divided into 4 equal sections, one for each dilution factor of a sample
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(Figure 2). 10 µL of each sample dilution were spotted onto the TSA plates in
the section respective of their dilution. Triplicates of samples were spotted in the
same quadrant. The spots were allowed to dry before plates were inverted and
incubated at 37°C aerobically for 24 hours. After 24 hours colonies were counted
and used to quantify average cells/mL by the following formula:
!"##$
= !"## !"#$% ! (10!"#$%"&' !"#$%&!! )
!"
Additional dilution factors are added because 10 µL of a 1:10 dilution is plated
resulting in additional dilution factors. The mean and standard deviation of
triplicates were then calculated.

10-1

10-1

10-2
10-4

10-2
10-4

10-3

10-3

Figure 2. Plating of serial dilution spots from a 96-well plate.
Survival Graphs
Graphs were constructed using the mean of cell counts under each
condition at the 24-hour time point. Red dotted lines on each graph represent the
detection limit of colony-forming units following serial dilution. The first dilution
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plated is a 1:10 dilution and 10µL of each dilution are plated. Therefore, the
limit of detection was calculated as 103 cells.
CFS Concentration and Dilution
CFS Concentration
CFS concentration was performed using the Savant Integrated SpeedVac
System ISS110. 1 mL aliquots of CFS were placed into the SpeedVac, which
uses heat and centrifugation to concentrate all non-liquid components within the
CFS. Once the liquid was evaporated, then the components were re-suspended
in 50 µL (20X) or 100 µL (10X) of H2O at pH 3.7 or 7.0.
CFS Dilution
CFS was diluted by adding either H2O pH 3.7 or PBS pH 3.7 to nonconcentrated CFS to obtain specific dilution factors, e.g. 90% CFS in a final
volume of 500 µL = 450 µL CFS and 50 µL H2O/PBS.
CFS Fractionation
Fast Protein Liquid Chromatography
An Amersham Biosciences FPLC was used to perform CFS fractionation
by size. 200 µL of CFS was injected into and run through a Superose 6 10/300
GL column in a Tris buffer pH 8.0 at 0.6 mL/min and collected in 1 mL fractions.
Additional runs were performed using PBS pH 3.7 rather than Tris. The first run
was performed at an elution rate of 0.6 mL/min collected in 1 mL fractions. The
second was run at rate of 0.06 mL/min and collected in 300 uL and/or 1 mL
fractions.
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Liquid-Liquid Organic Extraction
Liquid-liquid organic extraction was performed following a modified
Method76. Solvents were added starting at a 1:1 ratio to 10X concentrated CFS
samples or MRS. Samples were mixed by vortexing and then centrifuged to
separate organic and aqueous layers. The two layers were then separated by
pipet into sterile Eppendorf tubes. Sample liquids were then evaporated
overnight by SpeedVac and re-suspended as previously mentioned.
Immunofluorescent Stains
Live/Dead Staining
Cells incubated for 24 hours with Lc40 CFS were stained using the
Invitrogen LIVE/DEAD BacLight Bacterial Viability Kit77. This kit uses SYTO-9
and propidium iodide nucleic acid fluorophores. SYTO-9 readily enters cells with
and without damaged cell membranes. Propidium iodide is a larger molecule and
only enters cells with compromised membranes. Fluorophore properties are
listed in TABLE 1.
Fluorophore

Color

Molecular
Weight

Excitation

Emission

Syto978

Green

400

480nm

500nm

Propidium
Iodide79

Red

668

490nm

635nm

FM 4-6480

Red

608

515nm

640nm

Hoescht 3334281

Blue

616

361nm

497nm

TABLE 1. Fluorophore Properties.
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Membrane and Nucleic Acid Stains
Sample Preparation UPEC cultures were standardized to an OD600 of
1.0 prior to being incubated in CFS or MRS. 200 µL of sample were obtained
hourly and centrifuged at 13500 rpm for 1.5 minutes. Supernatants were
removed by pipette and samples were washed with 100 µL dH2O. Samples were
centrifuged again at 13500 rpm for 1.5 minutes. Supernatants were removed by
pipette and samples were re-suspended in 100 µL H2O.
Slide Preparation and Sample Staining 10 µL poly-L-Lysine was spotted
on microscope slides and allowed to sit for 1 minute. Liquid was then suctioned
off by vacuum pipette. Spots were washed 2x with H2O and dried. 10 µL of
sample was applied to Lysine spotted regions and allowed to sit for 10 minutes.
Excess sample was then suctioned off and the plates were dried. 0.05 µg
Hoeshct nucleic acid dye was added to samples in a dark room and incubated for
10 minutes. Excess dye was suctioned off and samples were washed once with
H2O. 0.01 µg FM 4-64 membrane specific fluorophore was then added to
samples, incubated for 30 seconds then excess dye removed and samples were
washed once. Coverslips were added to samples.
Imaging
Samples were imaged using the Leica DMIRB microscope at 1000X and
images were captured using MagnaFire 2.1C software. Images were obtained in
the red, blue, and bright fields. Images were merged using ImageJ software to
obtain final composite images.
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Statistics
One-way ANOVA and/or Mann-Whitney U tests were performed on raw
data to determine statistical significance between variables. Statistical
Significance will be denoted as follows: * = p<0.05, ** = p<0.01.

CHAPTER III
DETERMINATION OF KNOWN OR PROSPECTIVE BACTERICIDAL
MOLECULES PRESENT IN LACTOBACILLI CELL FREE SUPERNATANT
Introduction & Rationale
Using a novel culture technique, the Enhanced Quantitative Urine
Culture (EQUC), researchers have cultured organisms from the bladders of
women with and without urinary bladder symptoms5-8. Based on the organisms
cultured from these specimens, the co-culture frequency of various organisms
was determined9. The most commonly cultured Lactobacillus species from these
samples were L. crispatus, L. gasseri, L. iners, and L. jensenii. Intriguingly, of
these species, L. crispatus had a significantly lower co-culture frequency with
Escherichia coli and spotted lawn assays showed inhibition of uropathogenic E.
coli (UPEC) by L. crispatus cells, but not by L. gasseri9. The inhibition of UPEC
by L. crispatus, however, did not result in a zone of inhibition surrounding the L.
crispatus cell spot and L. crispatus cell free supernatant (CFS) did not show
inhibitory activity when spotted onto a UPEC lawn. In UPEC liquid cultures,
however, L. crispatus CFS inhibited growth and colony formation when plated9.
The ability of CFS to inhibit UPEC in liquid culture but not on agar plates
suggests the production of a secreted molecule that is concentration dependent
and/or not diffusible.
24
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Lactobacilli are a Gram-positive genus commonly cultured from the
gastrointestinal and urogenital tracts of women. Lactobacilli are widely
recognized as beneficial by providing an additional barrier beyond the host
defenses that inhibit pathogen colonization1-4. Most previous research attributes
bactericidal activity of Lactobacilli to the production of hydrogen peroxide (H2O2)
and organic acids, predominantly lactic acid1-3,11,44,46,68,70. Certain Lactobacillus
spp. also have been recognized to produce bacteriocins responsible for
pathogen inhibition2,4,35,82.
The concentration of lactic acid produced by Lactobacillus spp. has been
measured as ~62mM11. This concentration has been shown to only minimally
inhibit pathogen colony formation11. Acetic acid concentrations have been
measured in liquid cultures of L. sanfrancisco CB1 CFS as 13.8mM44, but the
concentration produced by other Lactobacillus spp. has not been cited. H2O2
production by various Lactobacilli has been measured with values ranging from
0.03 to 2.6mM45. Inhibitory concentrations of H2O2 necessary to achieve
inhibition required 2.5mM or greater, depending on the target pathogen11.
Hydrogen Peroxide Concentration in CFS
If H2O2 were responsible for the bactericidal activity of CFS, then we
would expect concentrations greater than the concentrations shown to inhibit
pathogens11. Measurement of H2O2 in CFS had a mean value of 11.51 +/0.000006 µM (TABLE 2), lower than concentrations measured45 by previous
researchers, and at least 10-fold lower than concentrations documented to result
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in pathogen inhibition . This result would suggest H2O2 is unlikely to
contribute to the bactericidal activity of CFS.
Organic Acid Concentration in CFS
CFS was prepared as indicated in Methods Sample Preparation. Organic
acid concentrations were determined using commercially available kits from
Boehringer Mannheim73-74. In short, each kit utilizes enzymes that convert
acetate or lactate to molecules that can be measured by UV-Vis Spectrometry.
Optical density (OD600) measurements of converted molecules can then be
used to determine concentrations of acetic and lactic acids present in CFS.
If acetic or lactic acids contribute to the bactericidal activity of CFS, as with
H2O2, we would expect concentrations similar to or in excess of concentrations
mentioned prior11. Acetic and lactic acid concentrations averaged 7.26 +/- 0.059
mM and 9.52 +/- 0.011 mM, respectively (TABLE 2). The acetic acid
concentration in CFS was considerably lower than the cited inhibitory
concentrations44. The lactic acid concentration present in CFS also was much
lower than concentrations documented to be necessary for pathogen inhibition11.
As with H2O2, the concentration of organic acids produced by L. crispatus are
unlikely to contribute to pathogen inhibition.
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CFS Molecule
Hydrogen Peroxide
Lactic Acid
Acetic Acid

Inhibitory
Concentration
2.5 mM11
70 mM11
8.33 mM44

Average
Lactobacilli
Concentration
0.03 – 2.6 mM45
62 mM11
13.8 mM44

Lc40 Produced
Concentration
11.51 +/- 0.000006 µM
9.52 +/- 0.011 mM
7.26 +/- 0.059 mM

Table 2. Concentrations of known inhibitory molecules in Lc40 CFS.
Hydrogen peroxide concentrations were determined by titration. Organic acid
concentrations were determined by UV-Vis spectrophotometry. H2O2 and organic
acid concentrations in CFS were lower than concentrations determined to exhibit
inhibitory activity against pathogens.
H2O2 and Organic Acid Conditioned-Medium against UPEC
To determine each molecule’s contribution to CFS bactericidal activity, 12
µM H2O2, 7.5 mM Acetic acid, and 8.5 mM Lactic acid were individually added to
MRS medium (pH 3.7) and incubated with UPEC overnight. The molecules also
were combined in MRS at the same final concentrations to determine their
combined bactericidal activity. As a positive control, CFS was added to UPEC
cultures as previously described and incubated overnight. CFUs were quantified
at 0- and 24-hour time points to determine the killing activity of conditioned
medium. MRS conditioned with H2O2 and/or organic acids at the measured
concentrations did not inhibit colony formation by UPEC (Figure 3). Thus, we
conclude that the bactericidal activity cannot be due to H2O2 and organic acids.
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Figure 3. Contributions of physiologic concentrations of H2O2 and organic
acids to bactericidal effects of L. crispatus CFS. 12µM H2O2, 8.5mM lactic
acid, and 7.5mM acetic acid were added to MRS medium pH 3.7 at
concentrations listed in Table 1. MRS supplemented with physiologically
produced concentrations of H2O2 and organic acids did not result in bactericidal
activity against UPEC.
Temperature and Time Stability
It has been shown here that H2O2 and organic acids are not responsible
for bactericidal effects of CFS. To begin investigating the type of molecule
responsible for bactericidal activity, as well as test molecule stability, CFS was
subjected to different storage temperatures and times. Proteins tend to denature
with extreme decreases or increases in temperature69,83. Boiling or cooling CFS
would, therefore, denature most proteins present within CFS and negate their
bactericidal effect against UPEC. Finally, lactic acid and hydrogen peroxide
degrade over time and at different temperatures. The half-life of lactic acid
ranges from 8-21 days, while hydrogen peroxide spontaneously decomposes to
O2 and H2O over time. The decomposition rate of H2O2 is increased with both
light exposure and at higher temperatures84.
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CFS was prepared as previously described. CFS samples were then
subjected to 100°C, 25°C, or 4°C temperatures. 100°C samples were held at
constant temperature for one hour then stored at 25°C. 4°C samples were stored
at 4°C. Samples from each temperature condition were then stored for either one
or fourteen days prior to UPEC incubation.
When UPEC was incubated with temperature- or time-conditioned CFS,
there was no change in bactericidal activity when compared to untreated CFS
(Figure 4). These results suggest typical proteins do not contribute to the
bactericidal activity of CFS.
I have previously shown that bactericidal activity is preserved when CFS is
stored at different temperatures for up to 2 weeks. I have not determined if CFS
is stable when stored for longer than two weeks. Therefore, I stored CFS at room
temperature (25°C) for three months and then tested its activity against UPEC.
CFS retains full bactericidal activity against UPEC when stored at room
temperature up to three months (Figure 5).
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Figure 4. CFS held up to 2 weeks at different temperatures retains its
bactericidal activity against UPEC. CFS samples were subjected to 100°C,
25°C, or 4°C temperatures and then stored for either one or fourteen days.
100°C samples were held at constant temperature for one hour before being
stored at 25°C for the specified times. 4°C samples were stored at 4°C for the
specified times. Conditioned CFS retained full bactericidal activity when
compared with unconditioned CFS.

Figure 5. CFS Activity after storage at room temperature for three months.
CFS retains full bactericidial activity against UPEC when stored up to three
months at room temperature (25°C).

CHAPTER IV
IDENTIFICATION OF THE INHIBITORY MOLECULE(S) IN CFS
CONTRIBUTING TO BACTERICIDAL ACTIVITY
Introduction & Rationale
To determine the type of molecule contributing to the bactericidal effects
against UPEC, enzymatic treatment was considered. Most enzymes are only
effective within narrow pH ranges and rarely under acidic conditions. The pH of
CFS after filter sterilization is 3.710. At this pH, enzymatic treatment would be
ineffective. Furthermore, CFS was previously determined to be ineffective at
more neutral or basic pH10,82. In one study, bactericidal activity of CFS was
regained after re-acidification of CFS82. Therefore, neutralization, enzymatic
treatment, and re-acidification may be a viable approach to degrade specific
classes of molecules and determine the class of the bactericidally active
molecule(s) in CFS.
Organic extraction is a common technique used to fractionate and/or
purify organic compounds. In liquid-liquid extraction, solvents are added to a
liquid sample and mixed. After centrifugation, the mixture resolves into two
separate phases, an aqueous phase and an organic phase. The aqueous phase
contains remnants of the original sample. Molecules from the original sample
sharing properties with the chosen solvent will migrate into the organic phase.
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Solvents are chosen based on their miscibility in water and/or other
properties, such as polarity85. General properties of solvents include miscibility,
organic versus inorganic, polar versus non-polar, and protic versus aprotic.
Miscibility refers to the ability of a solvent to mix with water. Organic solvents
contain carbon atoms whereas inorganic solvents do not. Polar solvents have a
net charge. Dipolar solvents move electrons between atoms and therefore have
a small moving charge throughout the molecule. Non-polar solvents have no net
charge. Protic solvents have the capability to donate H+ ions, whereas aprotic
solvents cannot.
Solvent properties are not mutually exclusive and some solvents have
many of the above properties. Polar protic solvents have a polar group on one
end (e.g. –OH) and a non-polar group on the other. Dipolar aprotic solvents have
a slight moving charge and cannot donate H+ ions to sample molecules. Nonpolar solvents tend to be hydrophobic and immiscible in water. Characteristics of
select organic solvents are listed in TABLE 3.
Solvent

IUPAC
Name

Solvent
Type

Miscible
with H2O

Polar

Polarity
Index

1-Butanol
Acetone
Acetonitrile
Benzene
Chloroform

n-Butanol
Acetone
Acetonitrile
Benzene
Chloroform

Immiscible
Miscible
Miscible
Immiscible
Immiscible

Polar
Dipolar
Dipolar
No
Slightly

0.586
0.355
0.460
0.111
0.259

Ethyl
Acetate
Petroleum
Ether

Ethyl
Acetate
n-Pentane

Alcohol
Ketone
Misc.
Hydrocarbon
Chlorinated
Solvent
Ester

Protic
or
Aprotic
Protic
Aprotic
Aprotic
aprotic
Aprotic

Immiscible

Dipolar

0.228

Aprotic

Hydrocarbon

Immiscible

No

0.009

Aprotic

Table 3. Solvent Properties. Properties of Solvents used in liquid-liquid organic
extractions (see Figures 16 & 17)85.
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1-Butanol

Acetonitrile

Chloroform

Petroleum Ether
Acetone

Ethyl Acetate

Benzene

Figure 6. Solvent Structures. Skeletal structural formulas of solvents used in
liquid-liquid organic extractions86.
Size Determination
Fast Protein Liquid Chromatography (FPLC)
I attempted FPLC to identify a fraction with bactericidal activity. This
method would facilitate purification and size range determination of bactericidally
active molecules. Three separate runs were performed with different eluents and
elution rates. No active fractions were identified (Figures 7-9).
Size Exclusion Spin Columns
I used low-binding centrifuge spin columns in an attempt to fractionate
samples by size exclusion and determine an approximate size range of the active
bactericidal molecule(s). 3-100kD columns were used. Size fractionation of CFS
resulted in fractions without bactericidal activity (data not shown). Size
determination at this time has been unsuccessful.
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Figure 7. FPLC of CFS Eluted in Tris pH 8.0. The sample was eluted at a rate
of 0.6mL/min and collected in 1mL fractions. Fractions were incubated with
UPEC for 24 hours. Fractions did not exhibit bactericidal activity.

Figure 8. FPLC of CFS Eluted in PBS pH 3.7. The sample was eluted at a rate
of 0.6mL/min and collected in 1mL fractions. Fractions were incubated with
UPEC for 24 hours. Fractions did not exhibit bactericidal activity.
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Figure 9. FPLC of CFS Eluted in PBS pH 3.7. The sample was eluted at a rate
of 0.06mL/min and collected in 300µL fractions. Fractions were incubated with
UPEC for 24 hours. Fractions did not exhibit bactericidal activity.
CFS pH Neutralization and Acidification
To treat CFS with enzymes targeting specific types of molecules, CFS
would need to be neutralized and re-acidified. CFS was neutralized to pH 7.0
using 1N NaOH then acidified to pH 3.7 using 1N HCl. The volume of NaOH/HCl
required resulted in less than a 10% dilution of CFS. However, neutralized and
re-acidified CFS lost all activity against UPEC (data not shown).
CFS Dilution and Concentration
CFS Dilution
I suspected that FPLC was unsuccessful due to dilution of the active
molecule(s) in CFS. To determine if CFS bactericidal activity was concentrationdependent, CFS was diluted in 10% increments in either dH2O or phosphatebuffered saline (PBS) adjusted to pH 3.7. Each dilution was incubated with UPEC
overnight and CFUs quantified at 0 and 24 hour time points.
When CFS was diluted by 75% (50% prior to adding UPEC culture), it lost
all bactericidal activity against UPEC (Figure 10). FPLC would dilute CFS
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substantially more than 75% and therefore this loss of activity would explain
why no active fractions could be identified from FPLC experiments. Bactericidal
activity appears to be salt-sensitive. Dilutions performed in PBS exhibited greater
activity against UPEC than dilutions performed in dH2O (Figures 11 & 12).
Together, these results show CFS bactericidal activity is salt-sensitive and
concentration-dependent.

Figure 10. CFS dilutions in H2O pH 3.7. CFS was diluted in 10% increments
prior to being added to UPEC cultures. Dilution in H2O shows a logarithmic
decrease in bactericidal activity against UPEC and CFS losses all activity at a
50% concentration.
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Figure 11. CFS dilutions in PBS pH 3.7. CFS was diluted in 10% increments
prior to being added to UPEC cultures. CFS loses bactericidal activity when
diluted 50%.
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Figure 12. CFS diluted in H2O versus PBS. CFS diluted in PBS retains
bactericidal activity at greater dilutions than when CFS is diluted in dH2O.
CFS Concentration
To determine if loss of activity due to CFS dilution could be controlled,
CFS was concentrated. CFS was aliquoted into Eppendorf tubes in 1 mL
volumes. Samples were then lyophilized by SpeedVac overnight. Samples were
re-suspended in 50-100 µL H2O pH 3.7 to obtain 10-20X concentrated CFS.
Concentrated CFS was then incubated with UPEC (Figure 13). Concentrated
CFS showed complete bactericidal activity against UPEC. Therefore,
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experiments resulting in dilution could be used to determine characteristics
and purify the bactericidal molecule(s) in CFS.

Figure 13. Concentrated CFS activity against UPEC. CFS was concentrated
20X by SpeedVac. Concentrated CFS retains full bactericidal activity against
UPEC.
CFS Activity on Agar Plates
Price and Diebel previously determined that CFS only showed bactericidal
activity in liquid culture but not on agar plates9-10. CFS activity has also been
determined to be pH-dependent with a loss of activity above pH 4.5 but in one
study acidification of CFS restored activity. To determine if inactivity of CFS of
plates was due to pH, I measured the pH. The pH of TSA plates is ~7.5 prior to
addition of CFS while CFS pH is 3.7. After plating 100µL of CFS pH is measured
as 3.7 but after CFS dries the plate pH increases to 7.0. pH was measured after
the plate was incubated for 24 hours and pH remains at 7.0. These results may
explain the lack of activity observed when CFS is spotted onto plates.
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I attempted to regain CFS bactericidal activity on agar plates by
performing lawn assays. UPEC overnight cultures were standardized to OD 1.0
and used to plate a lawn on TSA plates. Plates were allowed to dry. Sodium
Citrate buffer was adjusted to pH 3.7, 4.7, 5.7, or 6.7. 6mm paper disks were
saturated with 10µL sodium citrate or 10X CFS. Sodium citrate and CFS
saturated disks were placed adjacent to one another on dried UPEC plates. CFS
and sodium citrate-only disks were applied as controls. To determine whether
inhibition occurred below disks, I removed the disks using sterilized tweezers. I
then used a sterile loop to scrap the agar where the disk sat previously. The
sample was then struck onto a secondary fresh TSA plate and incubated
aerobically overnight. If inhibition occurred, I would expect to see either a zone of
inhibition surrounding CFS disks or a clearing below the disk and a lack of growth
on secondary plates.
Acidification by paper disks did not restore CFS activity on agar plates
(Figure 14). Samples from each plate grew UPEC overnight, showing that
inhibition did not occur beneath CFS- or sodium citrate-impregnated disks (data
not shown). Lack of activity cannot be due to CFS concentration because I used
10X CFS. CFS activity has been detected in liquid culture, but not plated
cultures. This may suggest the active molecule(s) may be sensitive to oxidation,
as liquid cultures do not have the same oxygen exposure as plated cultures do.
I used an alternative approach to verify inactivity of CFS on agar plates.
TSA was acidified using HCl to pH 3.6 prior to autoclaving and pouring plates.
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TSA with 1.5% agar did not solidify under acidic conditions. Agar concentration
was increased to 2.5% in an attempt to ensure solidification of TSA plates. TSA
with 2.5% agar concentration did not did not solidify. Therefore, attempts to
create acidic TSA plates were unsuccessful and at this time CFS activity has not
been detected on plates.

Figure 14. CFS Activity on Agar Plates Acidified by Sodium Citrate Paper
Disks. Localized acidification does not promote in bactericidal activity against
UPEC on agar plates. Sodium citrate (NaC) impregnated disks (left) and CFS
impregnated disks (right).
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Solvent Extraction
Once concentrated CFS was determined to exhibit full bactericidal activity
against UPEC, fractionation techniques resulting in CFS dilution could be utilized.
Liquid-Liquid Solvent Extraction was used to fractionate CFS and MRS. In short,
organic solvents have properties that differentiate them from water and allow
molecules present in a sample to move from an aqueous phase (water) to an
organic phase (solvent). In general, only molecules sharing properties with the
solvent will migrate to the organic phase. This method allows for both
fractionation and characterization of molecules that migrate to the organic phase.
20X concentrated CFS was used in all extractions. Solvent was added to
CFS and the mixture was vortexed. The samples were then centrifuged at 3,500
rpm for 10 minutes to separate aqueous and organic layers. Layers were
separated into Eppendorf tubes and placed in the SpeedVac overnight to
evaporate water and solvent from samples. Samples were re-suspended in 1 mL
H2O pH 3.7 and incubated with UPEC.
The bactericidal molecule(s) of CFS were soluble in polar solvents, but not
in non-polar solvents. When using 1 Solvent:1 sample ratios, incomplete
extraction by several solvents was evident by bactericidal activity in both
aqueous and organic fractions (Figure 15a). Moreover, acetone and acetonitrile
did not form an organic phase when added to MRS. Increased solvent volume
(5:1) resulted in more complete extraction of bactericidal molecules in the organic
phase (Figure 15b).
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To further purify the bactericidal molecule(s), sequential extraction was
performed using 1-butanol followed by ethyl acetate. The solvents were chosen
for the differences in their polarities and abilities to donate protons. Sequential
extraction of CFS resulted in a 1-butanol organic ethyl acetate aqueous phase
that lost activity. In contrast, the 1-butanol organic ethyl acetate organic phase
retained full bactericidal activity against UPEC (Figure 16a).
Protein concentrations were measured in MRS, 1X 24-hour CFS, 1X 48hour CFS, and 10X 48-hour CFS sequential extracts. The 1-butanol aqueous
phases contained proteins from samples, while the 1-butanol organic and ethyl
acetate extracts did not contain proteins (Figure 16b). The bactericidal
molecule(s) of interest appears to be (di)polar, non-proteinaceous, and organic in
nature.
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a)

b)

A = Aqueous phase
O = Organic phase
1-B = 1-Butanol, Chl = Chloroform, EA = Ethyl Acetate, PE = Petroleum
Ether, Benz = Benzene, Ace = Acetone, Aceto = Acetonitrile
Figure 15. Molecules contributing to CFS bactericidal activity are soluble in
select organic solvents. Solvents were added to 20X CFS. Aqueous and
organic layers were separated after extraction and solvents evaporated by
SpeedVac. Fractions were then re-suspended in H2O pH 3.7 and incubated with
UPEC. Molecules with bactericidal activity were soluble in 1-butanol, ethyl
acetate, acetone, and acetonitrile. Acetone and acetonitrile were miscible in
water and did not form organic layers when added to MRS. a) 1 CFS:1 solvent
incomplete extraction occurred. b) With increased solvent volume (1 CFS:5
solvent), more complete extracts were obtained, as evidenced by inactive
aqueous phases.

a)
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b)

Figure 16. Sequential Extraction of CFS in 1-Butanol and Ethyl Acetate
removes proteins and tri-peptides from CFS. Sequential extraction of 20X
CFS was performed using 1-butanol and ethyl acetate. 1-BA = 1-Butanol
Aqueous phase, 1-BO = 1-Butanol Organic phase, EAA = Ethyl Acetate Aqueous
phase, EAO = Ethyl Acetate Organic phase. a) Sequentially extracted fractions
retain bactericidal activity against UPEC. b) Sequential extraction removes
proteins and tri-peptides from MRS and CFS. Protein concentrations were
determined by BCA colormetric assay.

CHAPTER V
CHARACTERIZING AND DETERMINING CFS MECHANISM OF
BACTERICIDAL ACTIVITY AGAINST UPEC
Introduction & Rationale
CFS of Lactobacilli has been shown to have broad spectrum activity
against a wide array of pathogens2-4,11-12,34,44-45,47,67-69. Due to this broad
spectrum of activity, Lactobacilli may produce a molecule(s) with
decontamination or therapeutic properties. If the molecule(s) has potential for
use in ecological or medical fields, understanding the mechanism of action is
necessary prior to application.
Many pathogens have developed antibiotic resistance with associated
increases in morbidity and mortality46. The increased rate of antibiotic resistance
exceeds the development and identification of new antibiotic that may be
effective against resistant strains. Consequently, only a limited cache of
antibiotics exist to combat bacterial infections. Various bacterial species have
been identified to production molecules with bactericidal activity that may have
application as new antibiotic treatments. For instance, recently researchers have
identified lugdunin, a bacteriocidal molecule produced by Staphylococcus
lugdunensis with efficacy against the colonization of methicillin-resistant
Staphylococcus aureus, Glycopeptide intermediate-resistant S. aureus,
46

47
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vancomycin-resistant Enterococcus, and other infectious bacteria . If
Lactobacillus crispatus CFS contains a molecule that is effective at inhibiting a
broad spectrum of pathogens, then the molecule may be effective against
antibiotic resistant strains with downstream application as an antibiotic.
Various Lactobacillus spp. have been investigated for their bactericidal
activity. Inhibitory activity has been attributed to H2O2, organic acids, or
bacteriocins2,4,11,35,44-45,68,70,82. As shown previously, these molecules do not or
are unlikely to be responsible for the bactericidal activity of L. crispatus. The
capability of Lactobacilli to produce multiple bacteriostatic or bactericidal
molecules would suggest that the genus has multiple mechanisms of action
against pathogens. One study has shown that when a spotted lawn assay is
performed using L. crispatus cells on a UPEC lawn, UPEC does not grow within
the circumference of the cell spot, but a zone of inhibition did not form around the
cell spot. CFS spotted on the UPEC lawn did not inhibit UPEC growth9. This
would suggest either cell contact-dependent inhibition, production of a nondiffusible bactericidal molecule, or concentration-dependence of the bactericidal
molecule. Here, we investigate the mechanism by which L. crispatus inhibits
UPEC colony formation independent of cell contact.
CFS of Lactobacillus spp. has been documented to have inhibitory activity
when Lactobacilli are incubated in MRS for only 24 hours11. Inhibitory activity,
however, was not completely bactericidal as evidenced by the presence of viable
target pathogens. Other research has shown complete bactericidal effects of
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CFS against target pathogens after incubating Lactobacillus in MRS for 48
hours4,9-10,44,70. This information suggests two possibilities: 1) bactericidal
molecules are concentration-dependent, or 2) bactericidal molecules are only
produced during late-exponential growth or stationary phase.
In previous studies, a mechanism of action has not been proposed or
investigated. A first step to understand the mechanism of action would be to
observe the morphology of CFS incubated cells. The morphology of cells can
elucidate the type of damage occurring in cells and can assist in determining a
mechanism of action.
Kinetics and Susceptibility
Kinetics
Lactobacillus spp. CFS has been shown to inhibit pathogens within 24
hours of incubation2-4,9-11,35,44-45,67,82. However, the rate of killing has not been
determined. This knowledge is necessary if the active molecule is to be used in
ecological or medical fields for dosing purposes. Thus, UPEC was incubated in
CFS and colony-forming units were quantified over time to determine the kinetics
of bactericidal activity. Incubation of UPEC with CFS had a bactericidal effect that
began within 4 hours and resulted in undetectable CFUs by 16 hours. The
bactericidal effect was exponential over time with an initial decrease of 3.1 x 106
cells between 0- and 4-hour time points. Cell death was rapid; by 4 hours of
incubation in CFS, 70.00% of UPEC cells had died and by 6 hours 99.99% of
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cells were dead. Additionally, in all experiments performed, no UPEC CFUs
have been observed when incubated in CFS (Figure 17).

Figure 17. CFS kills UPEC logarithmically over time. Uropathogenic E. coli
(UPEC) was incubated with either L. crispatus cell free supernatant (black) or
MRS medium (grey). a) UPEC incubated in CFS decreased in viability
logarithmically over time. Loss of viable UPEC cells began within 4 hours and
were undetectable by 16 hours of incubation. The limit
CFS Activity based on L. crispatus Growth Phase and Incubation Time
It remains unclear if the bactericidal molecule(s) is constitutively produced,
produced only during a specific stage of growth, or when it reaches inhibitory
concentrations. It is also unknown if incubating L. crispatus longer results in
increased bactericidal activity. If the active molecule(s) is constitutively produced
but is concentration-dependent, then I would expect to see a gradual increase in
CFS activity with increased incubation time. If the active molecule(s) is not
produced constitutively, then I would expect to see a sudden increase in
bactericidal activity.
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48-hour liquid cultures of L. crispatus were standardized to an OD600 of
0.05 in 6 mL of fresh MRS. OD was measured every 6 hours to obtain a growth
curve. CFS was obtained from cultures at each time point. UPEC was incubated
in CFS from each time point and quantified after 24 hours of incubation to assess
bactericidal activity.
CFS did not have any bactericidal activity against UPEC until late
exponential/early stationary phase (Figure 18). This rapid increase in bactericidal
activity supports production of sufficient concentrations of bactericidal
molecule(s) during late exponential growth of L. crispatus.
I suspected the partial bactericidal activity observed against pathogens by
previous research11 was due to Lactobacillus incubation time in MRS. To
determine if bactericidal activity of Lactobacillus was due to incubation time or
was growth phase-dependent, CFS was obtained from L. crispatus cultures
every 24 hours and incubated with UPEC.
To determine when CFS gains activity and during which growth phase L.
crispatus either begins production of the active molecule(s) or when minimum
inhibitory concentration is reached, a growth curve was performed and CFS
obtained at each time point. UPEC was incubated with CFS obtained at each
time point and CFUs quantified.
Because 48-hour CFS has complete bactericidal activity against UPEC, it
was suspected that 24-hour CFS would show partial, but not complete activity as
seen by previous researchers11. Contrary to previous findings, 24-hour CFS did

51
not exhibit any bactericidal activity against UPEC. However, 48-, 72-, and 96hour CFS showed complete bactericidal activity against UPEC (Figure 19).
Longer incubation time did not exhibit an increased rate of bactericidal activity
within 4 hours of incubation. I conclude that CFS only becomes bactericidally
active when L. crispatus reaches early stationary phase and that longer L.
crispatus incubation time does not result in increased activity against UPEC.

Figure 18. Bactericidal activity of CFS against Lc40 growth. Growth curve of
L. crispatus clinical isolate Lc40. Bactericidal activity of Lc40 CFS obtained at
each measured growth curve time point. Lc40 CFS has a rapid increase in
bactericidal activity against UPEC between 36 and 42 hours suggesting
bactericidal molecule production occurs in late exponential/early stationary
phase.
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Figure 19. Effect of Lactobacillus incubation time on bactericidal activity. L.
crispatus was incubated in MRS up to 96 hours. CFS was obtained from the
culture every 24 hours and incubated with UPEC. MRS and 24-hour CFS
exhibited no bactericidal activity against UPEC. 48-, 72-, and 96-hour CFS
exhibited similar killing activity to one another and resulted in full bactericidal
activity against UPEC.
UPEC Susceptibility
In previous experiments, UPEC cultures had been standardized to an
OD600 of 1.0, which represents stationary growth phase. CFS had not been
tested against UPEC in exponential growth phase and therefore it remained
unclear if UPEC only experienced susceptibility to CFS during stationary phase
or if CFS was effective against UPEC independent of growth phase.
I inoculated TSB with an overnight UPEC (standardized to OD600 of 0.05)
culture and grew the culture aerobically until it reached an OD600 of 0.4, which is
representative of mid-exponential growth phase. UPEC and CFS were mixed in a
1:1 ratio as previously mentioned and CFUs were quantified at 0- and 24-hour
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time points. UPEC was susceptible to the active molecule(s) in CFS
regardless of growth phase (Figure 20).

Figure 20. Susceptibility to CFS based on UPEC growth phase. CFS
completely inhibits UPEC independent of UPEC growth phase.
Susceptibility of Select Gram-negative and Gram-positive Clinical
Isolates
Escherichia coli, Staphylococcus aureus, and Enterococcus faecalis are
known or suspected pathogens. S. aureus and E. faecalis are recognized for
their resistance to antibiotic treatment87. Research has shown that antibioticresistant strains of S. aureus are susceptible to CFS treatment10. E. faecalis
susceptibility has not been investigated.
Three E. coli strains were tested: CFT073 and NU14, both implicated in
pyelonephritis, and a clinical isolate (Ec901). Clinical isolates of S. aureus
(Sa910) and E. faecalis (Ef891) also were tested. The clinical isolates were
obtained from urine samples obtained during previous Wolfe laboratory studies5-

8,88

54
. Cultures were standardized to an OD600 of 1.0. Samples were incubated

in CFS as previously mentioned.
Bacteria incubated in MRS did not exhibit any change in CFU after 24
hours. In contrast, E. coli and S. aureus samples incubated in CFS showed
complete loss of CFUs by 24 hours. E. faecalis appeared largely resistant to CFS
with only a slight, but significant, loss of CFUs by 24 hours of incubation (Figure
21).
CFS susceptibility testing was further expanded in an attempt to
differentiate between commensal and pathogenic bacteria including UPEC with
plasmid mediated resistance to β-lactam antibiotics. Commensal bacteria tested
were L. gasseri, L. jensenii, and S. epidermidis. Pathogens tested were E. coli, K.
pneumoniae, P. mirabilis, P. aeruginosa, B. cereus, E. faecalis, and S. aureus.
Two of the E. coli isolates tested were transfected with a plasmid containing
blaNDM-1 which encodes for the New Delhi metallo-beta-lactamase 1 (NDM-1).
NDM-1 is an enzyme that confers resistance to β-lactam antibiotics. Βlactam antibiotics include penicillins, penams, cephalosporins, monobactams,
and carbapenams. This family of antibiotics has broad-spectrum activity against
both Gram-negative and Gram-positive bacteria. Β-lactams are generally used as
an initial antibiotic to treat bacterial infections.
CFS had bactericidal activity against all tested species with the exception
of B. cereus (TABLE 4). CFS only had partial bactericidal activity against P.
aeruginosa, E. faecalis, and S. epidermidis. CFS had full bactericidal activity
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against the remaining tested bacteria: E. coli (CFT073, NU14, and NDM+
clinical isolates Acl25 and F35231-1), K. pneumoniae, P. mirabilis, L. gasseri, L.
jensenii, and S. aureus.
Therefore, CFS appears to inhibit certain isolates of both Gram-negative
and Gram-positive bacteria. There was not a correlation between susceptibility to
CFS and whether a bacterium is deemed commensal or pathogenic. Additionally,
CFS had full bactericidal activity against multidrug-resistant bacteria (MDR). Due
to this potential broad-spectrum activity, the active molecule(s) is not likely to be
a bacteriocin, which tend to be active against only closely related organisms.
Results instead suggest that the active molecule(s) in CFS is most likely to be an
antibacterial AMP.
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MRS

*

*

*

CFS

Figure 21. CFS activity against select Gram-negative and Gram-positive
clinical isolates. Samples were incubated in CFS for 24 hours. E. coli and S.
aureus (Sa910) were susceptible to CFS but E. faecalis (Ef891) showed
substantial resistance.
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Bacterium
Escherichia coli
Acl25
F35231-1
Klebsiella pneumoniae
Proteus mirabilis
Pseudomonas
aeruginosa
Bacillus cereus
Enterococcus faecalis
Lactobacillus gasseri
Lactobacillus jensenii
Staphylococcus
aureus
Staphylococcus
epidermidis

Commensal or
Pathogen
Pathogen
Pathogen – NDM+
Pathogen – NDM+
Pathogen
Pathogen
Pathogen

Gram-negative,
Gram-positive
Negative
Negative
Negative
Negative
Negative
Negative

++
++
++
++
++
+

Pathogen
Pathogen
Commensal
Commensal
Pathogen

Positive
Positive
Positive
Positive
Positive

+
++
++
++

Commensal

Positive

+

Susceptibility

Table 4. Susceptibility of select Gram-positive and Gram-negative
organisms to CFS. Organisms were incubated in CFS or MRS for 24-48 hours
depending on the isolate’s recommended incubation time. Most organisms were
susceptible to the bactericidal activity of CFS with the exception of B. cereus.
++ = complete bactericidal activity, + = partial bactericidal activity, - = no
bactericidal activity.
CFS of Other Lactobacilli
A L. crispatus isolate with low bactericidal activity against UPEC had
previously been identified10. However, I was unable to culture this isolate and
replicate these results. If another isolate with low bactericidal activity could be
identified, then its genome could be sequenced and compared to an isolate with
high bactericidal activity. Variation in the genomes could identify genes of interest
that may be responsible for production of the bactericidal molecule(s).
CFS was obtained for three L. crispatus and one L. jensenii clinical
isolates. UPEC was incubated in CFS for 24 hours and CFUs quantified. CFS
from all Lactobacilli showed complete bactericidal activity against UPEC (Figure
22).
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Figure 22. CFS Activity of different Lactobacilli. UPEC was incubated in CFS
from L. crispatus (Lc) or L. jensenii (Lj) for 24 hours and CFUs quantified. CFS of
each Lactobacillus isolate tested showed complete inhibition of UPEC.
Imaging
As mentioned earlier, an initial step toward understanding the mechanism
of inhibition against UPEC should be observation of cell morphology. CFS may
cause damage to cells that is evident in bright field, immunofluorescent, and/or
transmission electron microscopy. Each of these techniques can elucidate the
type of damage occurring to cells that results in loss of viability within 24 hours.
Bright field microscopy will allow for basic analysis of cell morphology by
observation of overall cell structure and cytoplasmic content. For example,
damaged cells may show atypical morphology or blebbing. Immunofluorscent
microscopy allows for targeted imaging of specific cellular components such as
membranes and nucleic acids. Transmission electron microscopy (TEM) allows
for detailed observation of cell membranes and organization of intracellular
components.
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Phase Contrast Microscopy
UPEC incubated in CFS or MRS for 24 hours were observed at 1000X
under phase contrast microscopy. Treated cells appearred smaller and more
round compared to controls incubated in MRS medium (Figure 23). Zooming in

CFT073 at 24 hours

on images revealed decreased cytoplasmic density in CFS-incubated cells when
compared to MRS-incubated cells.
MRS

CFS
SCS

Figure 23. Phase contrast microscopy of UPEC incubated in CFS or MRS
(1000X). UPEC incubated in CFS (right) or MRS (left) for 24 hours were
observed at 1000X under phase contrast microscopy. CFS-incubated cells have
atypical morphology and decreased intracellular density.
Immunofluorescent Microscopy
Live/Dead Staining UPEC cells incubated in CFS or MRS were stained
using the BacLight Bacterial Viability Kit™. The kit uses two nucleic acid dyes,
Syto9 and propidium iodide. Syto9 is a green fluorescent dye that readily enters
all cells. Propidium iodide is a larger red dye that can only enter cells with a
compromised membrane.
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After 24 hours of incubation, cells were stained following the supplier’s
protocol. MRS incubated cells appeared green, suggesting intact membranes
(Figure 24). Approximately 70% of cells incubated in CFS stained red with
propidium iodide, suggesting compromised membranes.
Membrane and Nucleic Acid Staining UPEC cells incubated in CFS or
MRS were stained using FM 4-64 membrane and Hoescht 33342 nucleic acid
fluorophores to observe changes in morphology and membrane permeability
over time. FM 4-64 (red) stains plasma membranes and the fluorophore is
internalized rapidly over time80. Hoescht 33342 (blue) binds the minor groove of
DNA preferentially at A-T rich double-stranded regions81. I experimentally
determined that the Hoescht fluorophore only entered UPEC cells with
compromised membranes. CFS- and MRS-incubated UPEC were stained at 0-,
6-, 12-, and 18-hours after incubation.
After 6 hours of incubation, CFS-incubated cells appeared smaller than
MRS-incubated cells (Figure 25), consistent with phase contrast images. MRSincubated cells localized FM 4-64 within the membrane, while CFS-incubated
cells showed diffusion of FM 4-64 into the cytoplasm, suggesting increased rate
of internalization potentially due to compromised membrane integrity. Decreased
fluorescence intensity of CFS-incubated cell membranes, compared to MRSincubated cells, supports a loss of membrane integrity. The Hoescht fluorophore
was able to penetrate CFS-incubated UPEC membranes by 12 hours and was
strongly fluorescent at 18 hours, suggesting increased DNA binding. Hoescht did
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not enter MRS-incubated cells at any time point. As with Live/Dead staining,
these results suggest CFS-incubated cells have compromised membranes.
Hoescht fluorescence in CFS-incubated cells suggests the minor groove of DNA
and A-T rich double-stranded regions maintain their structural integrity at 12 and
18 hours after incubation. Compromised membrane integrity at 12- and 18-hour
time points correlates with loss of CFU in Figure 17.
I attempted to perform the previous procedure to compare UPEC against
a Gram-positive bacterium. This could not be achieved, as the Hoescht
fluorophore entered untreated Gram-positive cells (Figure 26). This suggests
exclusion of Hoescht in UPEC cells is due to the presence of an outer membrane
that is initially impenetrable to the Hoescht fluorophore. Because Hoescht enters
untreated S. aureus cells, a Live/Dead Stain also would not be a viable option
either as Hoescht and propidium iodide are similar in size and these cells would
fluoresce red, suggesting they are dead when that would not be the case.

MRS

CFS
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Figure 24. Live/Dead Stain of UPEC incubated in MRS or CFS. UPEC cells
incubated in CFS or MRS were stained after 24 hours. CFS-incubated cells have
compromised membranes as evidenced by entry of propidium iodide into cells
(red).
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Figure 25. Membrane and Nucleic Acid Staining of CFS- and MRSincubated UPEC. UPEC was stained with FM 4-64 membrane fluorophore (red)
and Hoescht 33342 nucleic acid fluorophore (blue). CFS-incubated cells showed
altered morphology by 6 hours of incubation and compromised membranes by 12
hours of incubation.
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E. coli

S. aureus

Figure 26. Membrane and Nucleic Acid Staining of E. coli versus S. aureus.
Hoescht fluorophores readily enter Gram-positive S. aureus but not Gramnegative E. coli prior to incubation in CFS.
Transmission Electron Microscopy
Transmission Electron Micrographs (TEM) were obtained of UPEC cells
incubated with CFS or MRS. MRS-incubated cells appeared ellipsoid with diffuse
cytoplasm (Figure 27a). CFS-incubated cells were smaller with irregular
morphology compared to MRS-incubated cells. The cytoplasm of CFS cells
appeared granular and less dense than MRS-incubated cells. Increased
magnification showed that CFS-incubated cells have undergone plasmolysis with
compromised cytoplasm and plasma membranes (Figure 27b/c).
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a)

b)

c)

Figure 27. Incubation of UPEC in CFS compromises the integrity of cell
cytoplasm and membranes. TEM of MRS-incubated UPEC (left) versus CFS
incubated UPEC (right) shows plasmolysis with compromised integrity of
cytoplasm and periplasm in CFS-incubated cells. a) 3000X, b) 8000X, c) 13000X
magnifications.

CHAPTER VI
DISCUSSION AND CONCLUSION
I propose that Lactobacillus crispatus produces a potentially novel dipolar,
organic molecule with broad-spectrum activity that is concentration-dependent
and salt-sensitive. This currently unidentified molecule(s) effectively and
reproducibly inhibits colony formation of UPEC, apparently by a mechanism that
causes plasmolysis. Identification of this molecule(s) is of high importance as it
may contribute to human health either as a decontaminant or as a therapeutic in
an era when antibiotic resistance is increasing.
I have shown that a urinary isolate of L. crispatus (Lc40) produces
concentrations of H2O2 and organic acids significantly lower than those required
to inhibit pathogen growth or survival (Table 2). MRS medium conditioned with
physiologically produced concentrations of H2O2 and/or organic acids did not
result in decreased UPEC viability when compared to unconditioned MRS
medium (Figure 3). Surprisingly, previous researchers have not performed this
simple experiment, i.e., to measure physiologically produced concentrations of
H2O2 and organic acids and to determine their contributions to CFS bactericidal
activity. Previous researchers have either measured concentrations of these
molecules and not tested the physiologically produced concentrations or tested
ranges of concentrations to determine at which concentration inhibition would
66
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occur. Furthermore, the bactericidal activity of CFS was stable even upon
boiling and over a range of storage times (Figures 4 & 5). Since H2O2 and
organic acids degrade with heat and with time, these observations support my
contention that H2O2 and organic acids cannot be responsible for the observed
bactericidal activity against UPEC. In light of my results, it seems counterintuitive
to attribute bactericidal activity of CFS to H2O2 or organic acids using the
methods of previous researchers and therefore I suggest previous research be
re-analyzed and re-interpreted.
Because the bactericidal activity of CFS was extremely stable, I also
conclude that the bactericidal molecule(s) is not likely to be proteinaceous in
nature. Proteins tend to denature with exposure to extreme temperatures and
temperature-conditioned CFS stored up to two weeks did not exhibit a decrease
in activity compared to unconditioned CFS (Figure 4). Moreover, 1-butanol
organic extraction removed the majority of proteins and peptides from CFS, yet
bactericidal activity was retained (Figure 16). I conclude that the active
molecule(s) is likely not proteinaceous. Together, these results suggest the
bactericidal activity of L. crispatus CFS is not due to H2O2, organic acids,
proteins, peptides, or bacteriocins; which have been previously credited for
pathogen inhibition.
Bacteriocins have many classes defined by various criteria. Based solely
on the definition of a bacteriocin it appears unlikely that the active molecule(s) in
CFS is a bacteriocin. The molecule(s) has broad-spectrum activity against
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distantly related genera such as Escherichia, Klebsiella, Proteus, and
Pseudomonas (Table 4). Based on this definition alone the only Classes of
bacteriocin the active molecule(s) could fall into are Subclass IIa or Class IV.
Subclass IIa is supported by the heat stability of the molecule(s) when full activity
is retained after heating CFS for one hour at 100°C (Figure 4). However, as
previously stated, the active molecule(s) acts against distantly related organisms
and is unlikely to be a traditionally characterized bacteriocin. Classes I and III are
composed of amphipathic molecules and should therefore be soluble in both
polar and non-polar solvents. This is not the case. The active molecule(s) was
only soluble is polar solvents suggesting the bactericidal molecule(s) is polar in
nature (Figures 15 & 16). Additionally, Class III bacteriocins result in cell lysis.
CFS’ mechanism of action against UPEC is shown to result in cellular
plasmolysis (Figure 27). Class IV bacteriocins have more variability in their
characterisitics and the molecule(s) may fit into this class. However, as stated the
molecule(s) act against distantly related genera and is most likely not a
bacteriocin. AMPs are more loosely defined and characterized based solely on
target organism. Therefore, I would suggest that the bactericidal molecule(s) in
CFS is an antibacterial AMP.
The bactericidal activity of CFS was sensitive to dilution and salt
concentration (Figures 10-12). Samples diluted in PBS, which has increased salt
concentration compared to H2O, retained activity at lower CFS concentrations
(Figure 12). Retention of activity in saline conditions is relevant to use of the
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active molecule(s) as a therapeutic agent. The human body has greater
salinity than H2O, making this result physiologically relevant; however, actual
salinity varies based on anatomical tissue type and location. Once the identity of
the active molecule(s) is determined, then its concentration in 1X CFS should be
measured. Based on dilution experiments, an approximate minimum inhibitory
concentration could be approximated and tested.
The pH of urine from healthy individuals ranges from 5.0-7.0. At this pH,
the bactericidal molecule(s) would be inactive. Lactobacillus spp. have been
shown to reduce the pH of the medium they are grown in. I would speculate that
in the bladder the genus would also reduce the pH of the environment. The
volume and surface area of the bladder are significantly larger than that of a test
tube. Therefore, I suggest that, rather than acidifying the entire bladder, L.
crispatus reduces the pH of its microenvironment. The localized acidification of
the microenvironment would allow for the bactericidal activity of secreted
antimicrobial molecule(s).
Incubating L. crispatus for 48 hours was required for maximum
bactericidal activity, as bactericidal activity did not occur until 42 hours of L.
crispatus growth; however, the effect was incomplete at this stage of growth
(Figure 18). Yet, incubating L. crispatus longer than 48 hours did not alter the
kinetics of bactericidal activity (Figure 19). This suggests the active molecule(s)
is only produced or reaches effective concentrations during late exponential
growth or in early stationary phase. Production or effective concentrations result
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only after L. crispatus reaches late exponential growth. Holding L. crispatus in
stationary phase beyond 48 hours did not result in increased bactericidal activity
against UPEC, further supporting production or effective concentration during
late exponential growth. To determine whether the molecule(s) is produced
constitutively 24-hour CFS could be concentrated and tested against UPEC to
evaluate bactericidal activity. If concentrated 24-hour CFS has bactericidal
activity then it would be hypothesized that L. crispatus constitutively produces
and secretes bactericidal molecule(s) rather than only producing the bactericidal
molecule(s) at late exponential growth phase. An alternative is a possible
saturation effect, where concentration beyond an undetermined threshold does
not exhibit increased efficacy or production of a very stable molecule(s) only
during late exponential growth and production does not continue through
stationary phase. Another variable may be the pH of L. crispatus growth medium
over incubation time. L. crispatus reduces the pH of MRS by 48 hours of
incubation. To determine if lack of bactericidal activity prior to 42 hours of
incubation is a pH effect, the pH of the growth medium would need to be
measured over time and bactericidal activity of CFS determined at each time
point. However, determination of when the cells produce the molecule(s) and
concentrations produced over L. crispatus growth must wait until the molecule(s)
is identified.
The active molecule(s) of CFS was soluble in polar/dipolar solvents,
including 1-butanol, acetone, acetonitrile, and ethyl acetate (Figure 15). This
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suggests that the active molecule(s) is polar in nature. 1-butanol, acetone, and
ethyl acetate contain oxygen atoms that are not involved in linkage within their
primary structure (Figure 6). Acetonitrile contains a terminal triple bonded
nitrogen atom. Acetone, acetonitrile and ethyl acetate are unsaturated (i.e.,
having double or triple bonded atoms). These properties suggest the active
molecule(s) in CFS may form hydrogen or polar covalent bonds with the
electronegative atoms of solvents, facilitating migration into the organic phase.
The molecule(s) was soluble in alcohol (1-butanol), ester (ethyl acetate), and
ketone (acetone) solvents, but not in hydrocarbon or chlorinated solvents (Table
3). This diverse solubility does not assist in classification of the molecule(s).
However, based on the solubility profile of the bactericidal CFS molecule(s), I
conclude the molecule(s) is a (di)polar organic molecule.
Attempts to fractionate CFS by size were unsuccessful (Figures 7-9).
FPLC failure was likely the result of high dilution factors that occur during the
liquid chromatography process. Size exclusion spin columns did not result in
dilution of CFS, but still resulted in fractions without bactericidal activity. It is
possible the active molecule(s) may be bound to spin column membranes, even
though low-binding membranes were used. These results may also suggest CFS
bactericidal activity requires more than one molecule. During size exclusion,
molecules may be separated and unable to form an active complex.
Furthermore, bactericidal activity may be due to a complex composed of
molecules of different sizes. An alternative is that one molecule requires a
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cofactor for activity. When CFS was diluted, the cofactor may not have been
present in high enough concentrations for activity. Because the active
molecule(s) can be extracted and retains full bactericidal activity, if a cofactor is
required it must possess similar properties to that of the active molecule(s), but
may also be of a different molecular weight.
Attempts to show CFS activity on agar plates were unsuccessful (Figure
14). Tryptic soy contains dibasic potassium phosphate buffer that maintains plate
pH at approximately pH 7.3. pH measurements of TSA and CFS plated on TSA
showed that acidic pH conditions are not retained after CFS dries on TSA. The
increase in pH is most likely due to the buffer in TSA and explains why
bactericidal activity has not been observed in plated conditions. Researchers
have conducted experiments with TSA buffered between pH 3.9-8.0, showing
TSA can be acidified. Plates acidified below 3.9 did not solidify even with
increased agar concentration. Therefore, CFS activity on acidified plates could
not be evaluated. Localized acidification by use of paper disks did not promote
CFS activity. Dibasic potassium phosphate buffer present in TSA may neutralize
the acidic paper disks and could explain the lack of CFS activity on agar plates.
To further investigate bactericidal activity on agar plates, a different medium or
modified TSA without dibasic potassium phosphate would need to be used. If a
buffer were to be used in the medium then it would have to be a buffer that is
capable of maintaining medium pH at 3.7. If activity is still not observed in plated
conditions then the active molecule(s) in CFS may be sensitive to oxidation. CFS
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is exposed to increased oxygen concentrations in plated conditions compared
to liquid cultures, but further experiments must be performed to evaluate
sensitivity to oxidation.
L. crispatus CFS showed efficacy against some species implicated in
various diseases and recognized to exhibit troubling rates of antibiotic resistance
(Figure 20, Table 4). CFS had full bactericidal activity against NDM+ UPEC with
resistance to β-lactam antibiotics, which include carbapenems, cephalosporins,
and penicillin derivatives (Table 4). Not only does this support broad-spectrum
activity but also shows the potential application as a treatment for MDR bacterial
infections. Carbapenems, cephalosporins, and penicillins are traditionally used
as a first line therapeutic for bacterial infections. With increased resistance, a
decrease in the rate of new antibiotic development, and a limited cache of
antibiotics it is critical to identify and develop new therapeutics against the
increasing prevalence of MDR bacterial infections. In a limited study, a low
efficacy isolate of L. crispatus was not identified (Figure 22). The CFS of the
Lactobacillus isolates tested all showed complete inhibition of UPEC. However,
in this preliminary screen, H2O2, organic acids, proteins, and bacteriocins could
not be excluded as contributing factors to the observed inhibition, as tests were
not performed to evaluate the concentration of each molecule in their CFS.
These data suggest the active molecule(s) produced by L. crispatus has broadspectrum activity and may be ubiquitous among other L. crispatus clinical
isolates tested.
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Incubation of UPEC with CFS had a bactericidal effect that was
exponential over time beginning within 4 hours and resulted in undetectable
CFUs by 16 hours (Figure 17). Cell death was rapid; by 4 hours of incubation in
CFS, 70% of UPEC cells had died and by 6 hours 99.99% of cells were dead.
Additionally, in all experiments performed, no UPEC colony-forming units have
been observed when incubated in CFS. This result suggests cells cannot
develop resistance to the active molecule(s) in CFS under conditions used. It is
possible that cells are exposed to extremely lethal concentrations of the active
molecule(s) and are unable to develop resistance due to rapid cell death.
Experiments would need to be conducted using sub-lethal concentrations, such
as 60% CFS, and cells passaged through multiple generations to determine if
resistance can be developed by UPEC. The bactericidal molecule(s) present in
CFS has also been shown to be extremely stable retaining full bactericidal
activity when stored for up to three months at room temperature (Figure 5).
Stability is of critical importance when considering use of this molecule(s) as a
therapeutic. That the CFS can be lyophilized or stored as a liquid up to three
months and still retain full activity could lead to its application as a therapeutic in
underdeveloped countries where the storage of a liquid or refrigerated
therapeutic may not be feasible.
Observation of CFS-treated UPEC by phase-contrast microscopy showed
smaller cells with a rounded morphology compared to UPEC incubated in MRS
(Figure 23). Cells also appeared to have decreased cytoplasmic density,
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suggesting intracellular components may be degraded or leaking from cells.
Live/Dead staining showed a majority of CFS-incubated cells had compromised
membranes, allowing propidium iodide (PI) to enter cells and stain nucleic acids
(Figure 24). This also showed that nucleic acids are retained within CFS-treated
cells after a 24-hour incubation period. Immunofluorescent staining with FM 4-64
membrane and Hoescht 33342 nucleic acid fluorophores showed an increased
number of cells with FM 4-64 internalization at 6 hours in CFS-incubated cells,
suggesting membranes are compromised by this time. Whether membrane
damage is the cause of death or a secondary effect to cell death has not been
determined at this time. Hoescht was seen to enter CFS-incubated cells by 12
hours (Figure 25). CFS-incubated cells had increased fluorescence at 18 hours
compared to MRS-incubated cells, which do not internalize Hoescht at any time
point. I could not determine if Gram-positive species show the same permeability
when incubated with CFS as Gram-negative E. coli, as S. aureus readily
internalized both Hoescht and FM 4-64 prior to incubation with CFS (Figure 26).
This result is consistent with results of Gram-positive bacterium research, where
Hoescht is used in experiments as a nucleic acid fluorophore for live cells. To
determine if Gram-positive species show similar damage to E. coli after
incubation in CFS, we would need to obtain TEMs to observe detailed
cytoplasmic and morphological differences compared to MRS-incubated cells.
Alternatively, we could use a different fluorophore, one that permeates Gramnegative and Gram-positive cells in a similar manner. PI intercalates between
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intact double-stranded DNA. Hoescht binds the minor groove of DNA at A-T
rich regions. The ability of PI and Hoescht to bind the DNA of CFS-incubated
cells suggests DNA architecture was not affected by the active molecule(s) in
CFS since DNA remained double-stranded and A-T rich minor groove regions
were apparently intact. Closer analysis by TEM of UPEC incubated in CFS
revealed atypical morphology compared to MRS-incubated cells (Figure 27).
Cells showed signs of plasmolysis with compromised plasma membranes and
granulated cytoplasmic contents. Granular cytoplasmic contents could explain
the appearance of less dense cytoplasm observed by phase contrast imaging
(Figure 23).
Much still needs to be learned about the bactericidal activity of L. crispatus
CFS. Many characteristics of the bactericidal molecule(s) in CFS have been
determined; however, the identity of the molecule(s) has still not been elucidated.
Identification of the molecule(s) will assist in further determining characteristics of
the molecule(s), potential L. crispatus genes responsible for production of the
molecule(s), a mechanism of action, minimum inhibitory concentration, and
potential applications.
Characterization could include the classification and structure of the
molecule(s). Determination of class and structure will provide information about
how the molecule(s) acts against its target and in which anatomical or ecological
niches, if any, it would be active. If the molecule(s) is only active in specific
anatomical or ecological niches then modification of its structure could result in a
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molecule(s) with more diverse activity in various niches. As the active
molecule(s) is pH-sensitive, its structure could be modified to enable activity in a
more pH neutral environment.
Determination of the gene responsible for production of the molecule(s) is
another important step toward use of the molecule(s) as a therapeutic. Once the
gene is determined, it can then be introduced into a bacterium with a shorter
generation time. Prior to introduction, however, the mechanism of action would
need to be determined. Insertion of the gene into a susceptible bacterium would
ultimately result in decreased production of the active molecule(s) compared to L.
crispatus. By determining the mechanism of action we may be able to alter the
genome of a bacterium deeming it resistant; and consequently, the ability to
produce the active molecule(s) more rapidly than L. crispatus. If the molecule(s)
can be used as a decontaminant or therapeutic then more rapid production (and
potentially higher yield) could help to result in quicker distribution as well as
minimize cost.
Based on the results presented here, I suggest that L. crispatus produces
an extremely stable, potentially novel dipolar, organic molecule with broadspectrum activity that is concentration-dependent, salt-sensitive and that results
in plasmolytic action against its target. Identification of the molecule(s) could lead
to its application as a decontaminant or therapeutic contributing to human health.
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